CLINICAL_TRIALS
trial_result
· 2019-02-20
Clinical Trial Update: Sitagliptin and Glucagon Counterregulation [Phase 4]
Summary
Phase 4 clinical trial update evaluating sitagliptin's effect on glucagon counterregulation in adults with type 2 diabetes; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lund University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2019-02-20